Gene: FAM241A
Official Full Name: family with sequence similarity 241 member Aprovided by HGNC
Gene Summary: Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26511 | FAM241A Knockout cell line (HeLa) | Human | FAM241A | 1:3~1:6 | Negative | Online Inquiry |
KO26512 | FAM241A Knockout cell line (HCT 116) | Human | FAM241A | 1:2~1:4 | Negative | Online Inquiry |
KO26513 | FAM241A Knockout cell line (HEK293) | Human | FAM241A | 1:3~1:6 | Negative | Online Inquiry |
KO26514 | FAM241A Knockout cell line (A549) | Human | FAM241A | 1:3~1:4 | Negative | Online Inquiry |
FAM241A Gene Knockout Cell Lines are specially engineered cellular models designed to facilitate the study of the FAM241A gene's function by enabling researchers to investigate the phenotypic consequences of its absence. These knockout cell lines are generated using advanced CRISPR-Cas9 technology, in which specific sequences of the FAM241A gene are precisely disrupted, allowing for targeted investigations into the role of this gene in various biological processes.
The primary function of FAM241A Gene Knockout Cell Lines lies in their ability to provide a simplified model for studying gene function and its implications in cellular pathways, disease mechanisms, and therapeutic responses. By observing these knockout cells, scientists can elucidate the pathways in which FAM241A is involved, assessing changes in cellular behavior such as proliferation, differentiation, and apoptosis. This is particularly relevant in cancer research, where understanding gene knockouts can shed light on tumorigenesis and potential treatment targets.
In the scientific community, these cell lines hold significant value as they enable high-throughput screening for drug discovery, biomarker development, and the assessment of genetic interventions. They serve as invaluable tools in both research and clinical settings, as researchers can use them to validate the implications of genetic alterations in diseases that correlate with dysregulated FAM241A expression.
One key advantage of FAM241A Gene Knockout Cell Lines compared to traditional models is their specificity and reproducibility, providing a clear-cut approach to genetic manipulation that enhances experimental reliability. They also offer time and cost efficiency, yielding robust results that can accelerate the pace of research. Furthermore, these cell lines are extensively optimized for a variety of applications, enhancing their versatility across different experimental frameworks.
For researchers and clinicians focused on genetic research and therapeutic development, FAM241A Gene Knockout Cell Lines present a unique opportunity to deepen understanding of genetic contributions to diseases and to inform clinical strategies aimed at gene-targeted interventions. With a commitment to advancing biological research, our company provides high-quality, reliable cellular models designed to empower today's scientific endeavors, backed by our expertise in genetic engineering and cell biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.